Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,427.00
+5.00 (0.09%)
Aug 22, 2025, 3:30 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 648.28 billion as of August 22, 2025. Its market cap has increased by 1.86% in one year.
Market Cap
648.28B
Enterprise Value
625.53B
Revenue
133.04B
Ranking
n/a
PE Ratio
28.38
Stock Price
5,427.00
Market Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 648.28B, an increase of 292.42%. That is a compound annual growth rate of 15.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 648.76B | -3.69% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | 349.87B | 45.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,935.39B |
| Divi's Laboratories | 1,600.24B |
| Cipla | 1,286.59B |
| Apollo Hospitals Enterprise | 1,139.71B |
| Mankind Pharma | 1,073.14B |
| Zydus Lifesciences | 991.95B |
| Fortis Healthcare | 715.36B |
| Aurobindo Pharma | 604.61B |